Holen Sie sich die Stockscreener-App
12.66
4.87%
0.62
Schlusskurs vom Vortag:
$12.04
Offen:
$12.21
24-Stunden-Volumen:
18,075
Relative Volume:
0.53
Marktkapitalisierung:
$552.15M
Einnahmen:
$9.74M
Nettoeinkommen (Verlust:
$7.19M
KGV:
77.34
EPS:
0.1637
Netto-Cashflow:
$2.25M
1W Leistung:
-7.90%
1M Leistung:
-45.08%
6M Leistung:
-63.13%
1J Leistung:
-67.91%
1-Tages-Spanne:
$12.01
$13.69
1-Wochen-Bereich:
$11.01
$13.69
52-Wochen-Spanne:
$10.50
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Compare NNNN vs ISRG, BDX, MDLN, ALC, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
12.58 | 557.42M | 9.74M | 7.19M | 2.25M | 0.1637 |
ISRG
Intuitive Surgical Inc
|
426.49 | 150.88B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
157.46 | 43.56B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
42.81 | 36.52B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.22 | 33.97B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.34 | 30.41B | 5.54B | 1.52B | 1.74B | 10.37 |
Anbio Biotechnology Aktie (NNNN) Neueste Nachrichten
Top 3 Health Care Stocks That May Rocket Higher In July - Benzinga
Top 3 health care stocks you'll regret missing in Q2 - MSN
Price to book forward of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Price to earnings forward of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Enterprise value to revenue forward of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Price to earnings forward of Anbio Biotechnology Class A – FWB:N3B - TradingView
Anbio Biotechnology (NNNN) Stock Price Today - CoinMarketCap
NNNN PE Ratio & Valuation, Is NNNN Overvalued - Intellectia AI
Anbio Biotechnology (NNNN) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Anbio Biotechnology (NNNN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Anbio Biotechnology Soars After Surprise Media Spotlight - TipRanks
Anbio Biotechnology (NNNN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Anbio Biotechnology (NNNN) Institutional Confidence - TradingKey
Anbio Biotechnology (NNNN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Anbio Biotechnology (NNNN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga
Anbio Biotechnology (NNNN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Anbio Biotechnology (NNNN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Anbio Biotechnology (NNNN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Anbio Biotechnology Soars as Geopolitics Ignite Rebound - TipRanks
Why Anbio Biotechnology Class A Shares Are Sliding - TipRanks
Anbio Biotechnology (NNNN) director ZHANG MICHAEL W.C files initial Form 3 - Stock Titan
Director David H. Hsu files initial Form 3 at Anbio Biotechnology (NNNN) - Stock Titan
Why Anbio Biotechnology Shares Keep Sinking Today - TipRanks
Anbio Biotechnology (NNNN) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
Why Anbio Biotechnology Class A Shares Are Sinking - TipRanks
Anbio’s Stock Has Been On A Wild Run Since Its IPO - Finimize
Anbio Biotechnology (NNNN) Faces Sharp Pullback: Key Levels and Market Sentiment After 14.88% DeclinePercent Above MA - newsline.com
Anbio Biotechnology (NNNN) Drops 7.2% as Selling Pressure IntensifiesOpening Range Breakout - newsline.com
Why Anbio Biotechnology Class A Stock Is Sliding - TipRanks
Why Anbio Biotechnology NNNN Shares Are Surging Now - TipRanks
Why Anbio Biotechnology Shares Are Tumbling Today - TipRanks
Anbio Biotechnology Holds Steady Near $34.41 as Trading Volume Remains ModerateThrowback Trade - The Legal Advocate
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
Anbio Biotechnology (NNNN) Stock Forecast and Price Target 2026 - MarketBeat
NNNNAnbio Biotechnology Stock Price and Quote - Finviz
Anbio Biotechnology (NNNN) Holds Near Support as Selling Pressure ModeratesAAII Bearish - newsline.com
Assessing Anbio Biotechnology (NNNN) Valuation After Strong Recent Share Price Momentum - simplywall.st
Anbio Biotechnology (NNNN) Share Price Forecast & Price Target - Investing.com UK
Why Anbio Biotechnology Shares Are Tumbling Now - TipRanks
Anbio Biotechnology Shareholders Approve Sweeping Capital and Governance Changes - TipRanks
Control shifts as Anbio (NNNN) boosts Class B voting power - Stock Titan
Why Anbio Biotechnology Shares Won’t Stop Climbing - TipRanks
Uncovering 3 Undiscovered Gems in the US Market - Yahoo Finance
Top Hemab Therapeutics (COAG) Competitors 2026 - MarketBeat
TradingKey - TradingKey
Number of shareholders of Anbio Biotechnology – NASDAQ:NNNN - TradingView
Why Anbio Biotechnology Class A Shares Keep Sliding - TipRanks
Why are smart money investors paying attention to Anbio (NNNN)? (Momentum Fading) 2026-05-07Overvalued Stocks - Newser
Hemab Therapeutics Hldgs (COAG) Stock Analysis Report | Financials & Insights - Benzinga
Finanzdaten der Anbio Biotechnology-Aktie (NNNN)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.23%
2.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):